PA
PHR icon

PharVision Advisers’s Phreesia PHR Stock Holding History

PharVision Advisers’s Portfolio PHR Stock Details PHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.2K Sell
11,833
-9,803
-45% -$130K 1.01% 47
2025
Q4 		$366K Buy
21,636
+6,982
+48% +$144K 0.19% 158
2025
Q3 		$345K Buy
+14,654
New +$399K 0.19% 146
2025
Q2 		– Sell
-8,622
Closed -$220K – 389
2025
Q1 		$220K Sell
8,622
-3,384
-28% -$92K 0.31% 169
2024
Q4 		$302K Buy
+12,006
New +$257K 0.26% 149

Other funds holding PHR

PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PharVision Advisers's PHR Position: Q1 2026 in Review

PharVision Advisers reduced its Phreesia (PHR) stake by 45% in Q1 2026, selling an estimated $130K and leaving 11,833 shares worth $99.2K. The position accounts for 1.01% of the portfolio, ranked #47.

PharVision Advisers first reported a position in PHR in Q4 2024 and has held it in 5 quarters since. The position peaked at $366K in Q4 2025. 244 funds tracked by Wall St. Rank hold PHR as of Q1 2026.

  • PharVision Advisers held 11,833 shares of Phreesia worth $99.2K as of Q1 2026.
  • PharVision Advisers sold 9,803 Phreesia shares in Q1 2026, an estimated $130K.
  • Phreesia made up 1.01% of PharVision Advisers's portfolio in Q1 2026, its #47 holding.
  • PharVision Advisers first reported a position in Phreesia in Q4 2024 and has held it in 5 quarters since.
  • PharVision Advisers's Phreesia position peaked at $366K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Phreesia as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.